0001615898-20-000002.txt : 20201218 0001615898-20-000002.hdr.sgml : 20201218 20201218124434 ACCESSION NUMBER: 0001615898-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201218 DATE AS OF CHANGE: 20201218 EFFECTIVENESS DATE: 20201218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pear Therapeutics, Inc. CENTRAL INDEX KEY: 0001615898 IRS NUMBER: 463597074 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-383679 FILM NUMBER: 201398777 BUSINESS ADDRESS: STREET 1: 200 STATE STREET, 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6469322774 MAIL ADDRESS: STREET 1: 200 STATE STREET, 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 D 1 primary_doc.xml X0708 D LIVE 0001615898 Pear Therapeutics, Inc. 200 STATE STREET, 13TH FLOOR BOSTON MA MASSACHUSETTS 02109 6179257848 DELAWARE None None Corporation true Corey McCann c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Director Andrew Schwab c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Director Zack Lynch c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Director Timothy Petersen c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Director Elena Viboch c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Director Ms. Viboch was elected as a Director subsequent to the Date of First Sale. Nancy Schlichting c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Director Ms. Schlichting was elected as a Director subsequent to the Date of First Sale. Christopher Guiffre c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Julia Strandberg c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Yuri Maricich c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Ronan O'Brien c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Other Health Care Decline to Disclose 06b false 2020-12-07 false true false 0 111999925 111999925 0 Includes $31,999,996 of proceeds used to repurchase securities, resulting in $79,999,929 of gross proceeds after the repurchase (before expenses). false 20 0 0 0 false Pear Therapeutics, Inc. /s/ Christopher Guiffre Christopher Guiffre CFO & COO 2020-12-18